Tokyo, Oct. 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059281) titled 'Effects of test food consumption on the knee joint in healthy Japanese' on Oct. 3.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - MYCARE Co., Ltd.

Condition: Condition - Healthy Japanese Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To verify the effects of test food consumption on the knee joint in healthy Japanese. Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - Duration: 12 weeks Test product: Test food Interventions/Control_2 - Duration: 12 weeks Test product: Placebo food

Eligibility: Age-lower limit - 20 years-old = 66 mm

7. Individuals with low "Conditions in daily life" score of the JKOM Key exclusion criteria - 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction

2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD)

3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases

4. Individuals who are taking "Foods for Specified Health Uses" or "Foods with Functional Claims"

5. Individuals who are taking or using medications (including herbal medicines) or supplements

6. Individuals who are allergic to medicines or foods related to the test product, particularly those who are allergic to shrimp or crab

7. Individuals who are pregnant, lactating, or planning to become pregnant during this study

8. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study

9. Individuals who regularly consume "Foods for Specified Health Uses" or "Foods with Functional Claims" (e.g., N-acetylglucosamine, salmon nasal cartilage-derived proteoglycan or undenatured type II collagen, glucosamine hydrochloride, curcumin, skipjack-derived elastin peptide, or collagen peptides)

10. Individuals who engage in intense, joint-loading exercise (e.g., ball sports such as soccer, baseball, basketball, or jogging, running, skiing, or snowboarding)

11. Individuals who use a cane or joint support, or who may require their use during the study period

12. Individuals who are judged as ineligible to participate in this study by the physician Target Size - 166

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2025 Year 09 Month 10 Day Date of IRB - 2025 Year 09 Month 10 Day Anticipated trial start date - 2025 Year 10 Month 03 Day Last follow-up date - 2026 Year 05 Month 06 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067813

Disclaimer: Curated by HT Syndication.